Konruns(SH:603590) Zheng Xing Xing Ye Ri Bao·2025-09-02 08:59Market Overview - The biopharmaceutical sector experienced a decline of 0.51% on September 2, with Kangchen Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3858.13, down 0.45%, while the Shenzhen Component Index closed at 12553.84, down 2.14% [1] Stock Performance - Notable gainers in the biopharmaceutical sector included: - Changchun High-tech: closed at 124.71, up 10.00% with a trading volume of 220,900 shares and a turnover of 2.734 billion [1] - Wuxi Jinghai: closed at 30.19, up 9.03% with a trading volume of 72,300 shares and a turnover of 214 million [1] - Sanofi Biopharmaceuticals: closed at 55.12, up 4.10% with a trading volume of 133,600 shares and a turnover of 738 million [1] - Conversely, Kangchen Pharmaceutical saw a significant decline, closing at 57.36, down 7.17% with a trading volume of 117,700 shares and a turnover of 708 million [2] - Other notable decliners included: - Kexing Pharmaceutical: closed at 43.16, down 4.87% [2] - Wu Fan Biopharmaceuticals: closed at 55.37, down 4.52% [2] Capital Flow - The biopharmaceutical sector saw a net outflow of 461 million from institutional investors, while retail investors contributed a net inflow of 262 million [2] - The capital flow for specific stocks indicated: - Changchun High-tech had a net inflow of 424.16 million from institutional investors, but a net outflow of 244 million from retail investors [3] - Sanofi Biopharmaceuticals experienced a net inflow of 63.64 million from institutional investors, with a net outflow of 72.52 million from retail investors [3]